中枢神经系统血管炎与头痛

doi:10.3969/j.issn.1673-5765.2022.05.005

摘要/Abstract

摘要： 累及中枢神经系统的血管炎被称为中枢神经系统血管炎。头痛是中枢神经系统血管炎的非特异表现之一，也是其中最常见的神经系统症状。目前按照2012年Chapel Hill会议（Chapel Hill consensus conference，CHCC）血管炎分类标准将血管炎按照受累血管大小不同进行分类。血管炎所致头痛的发病机制不明，血脑屏障及神经血管单元的破坏在血管炎头痛中可能起到重要作用。不同类型血管炎累及中枢神经系统的发生率以及头痛的发生时机和特点有差异。识别血管炎相关的头痛，并快速进行诊断至关重要，以免进行不必要的治疗或导致严重神经系统后遗症。

文章导读： 不同类型血管炎所致头痛发生时机及特点有差异，血脑屏障及神经血管单元破坏在其中起重要作用。

关键词: 血管炎; 中枢神经系统血管炎; 原发性中枢神经系统血管炎; 头痛

Abstract: Vasculitis involving the central nervous system (CNS) is widely referred to CNS vasculitis. Headache is one of the non-specific manifestations of CNS vasculitis, and it is also the most common neurological symptom. At present, according to the 2012 Chapel Hill consensus conference (CHCC) vasculitis classification criteria, vasculitis is classified according to the size of the involved blood vessels. The pathogenesis of headaches caused by vasculitis is unknown. The destruction of the blood-brain barrier and neurovascular units may play an essential role in vasculitis-related headaches. The incidence of different types of vasculitis involving the CNS, as well as the timing and characteristics of headaches are different. It is crucial to recognize vasculitisrelated headaches and make a quick diagnosis so as to avoid unnecessary treatment or leading to severe neurological sequelae.

Key words: Vasculitis; Central nervous system vasculitis; Primary angiitis of central nervous system; Headache

丁曼, 肖哲曼. 中枢神经系统血管炎与头痛[J]. 中国卒中杂志, 2022, 17(05): 466-471.

DING Man, XIAO Zheman. Central Nervous System Vasculitis and Headache[J]. Chinese Journal of Stroke, 2022, 17(05): 466-471.

参考文献

[1] Headache Classification Committee of the International Headache Society（IHS）. The international classification of headache disorders，3rd edition[J]. Cephalalgia，2018，38（1）：1-211.
[2] NEUWELT E A，BAUER B，FAHLKE C，et al. Engaging neuroscience to advance translational research in brain barrier biology[J]. Nat Rev Neurosci，2011，12（3）：169-182.
[3] DANEMAN R. The blood-brain barrier in health and disease[J]. Ann Neurol，2012，72（5）：648-672.
[4] SALVARANI C，BROWN R D JR，CALAMIA K T，et al. Primary central nervous system vasculitis：analysis of 101 patients[J]. Ann Neurol，2007，62（5）：442-451.
[5] JOHN S，HAJJ-ALI R A. Headache in autoimmune diseases[J]. Headache，2014，54（3）：572-582.
[6] GONZALEZ-GAY M A，VAZQUEZ-RODRIGUEZ T R，LOPEZ-DIAZ M J，et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica[J]. Arthritis Rheum，2009，61（10）：1454-1461.
[7] GONZALEZ-GAY M A，BARROS S，LOPEZDIAZ M J，et al. Giant cell arteritis：disease patterns of clinical presentation in a series of 240 patients[J]. Medicine（Baltimore），2005，84（5）：269-276.
[8] AREND W P，MICHEL B A，BLOCH D A，et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis[J]. Arthritis Rheum，1990，33（8）：1129-1134.
[9] KIM H J，SUH D C，KIM J K，et al. Correlation of neurological manifestations of Takayasu's arteritis with cerebral angiographic findings[J]. Clin Imaging，2005，29（2）：79-85.
[10] PAGNOUX C，SEROR R，HENEGAR C，et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa：a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French vasculitis study group database[J]. Arthritis Rheum，2010，62（2）：616-626.
[11] WALZ LEBLANC B A，KEYSTONE E C，FELTIS J T，et al. Polyarteritis nodosa clinically masquerading as temporal arteritis with lymphadenopathy[J]. J Rheumatol，1994，21（5）：949-952.
[12] BERT R J，ANTONACCI V P，BERMAN L，et al. Polyarteritis nodosa presenting as temporal arteritis in a 9-year-old child[J]. AJNR Am J Neuroradiol，1999，20（1）：167-171.
[13] YUN S H，YANG N R，PARK S A. Associated symptoms of Kawasaki disease[J]. Korean Circ J，2011，41（7）：394-398.
[14] G U I L L E V I N L，DURAND-GASSELIN B，CEVALLOS R，et al. Microscopic polyangiitis：clinical and laboratory findings in eighty-five patients[J]. Arthritis Rheum，1999，42（3）：421-430.
[15] TAUSEEF A，ASGHAR M S，AMIR M，et al. Microscopic polyangiitis：an incidental finding in a patient with stroke[J]. J Community Hosp Intern Med Perspect，2020，10（1）：50-54.
[16] REINHOLD-KELLER E，BEUGE N，LATZA U，et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis：long-term outcome in 155 patients[J]. Arthritis Rheum，2000，43（5）：1021-1032.
[17] N I SH I NO H，RUBINO F A，DE R E M E E R A，et al. Neurological involvement in Wegener's granulomatosis：an analysis of 324 consecutive patients at the Mayo Clinic[J]. Ann Neurol，1993，33（1）：4-9.
[18] VĂCĂR AŞ V，RADU R M，CUCU E，et al. Multiple strokes and cerebral microangiopathy in a patient with Churg-Strauss syndrome[J]. Med Pharm Rep，2021，94（1）：121-124.
[19] AL-ARAJI A，KIDD D P. Neuro-Behçet's disease：epidemiology，clinical characteristics，and management[J]. Lancet Neurol，2009，8（2）：192-204.
[20] B O R H A N I H A G H I G H I A，AFLAKI E，KETABCHI L. The prevalence and characteristics of different types of headache in patients with Behçet's disease，a case-control study[J]. Headache，2008，48（3）：424-429.
[21] ANTONIOS N，SILLIMAN S. Cogan syndrome：an analysis of reported neurological manifestations[J]. Neurologist，2012，18（2）：55-63.
[22] PAGNINI I，ZANNIN M E，VITTADELLO F，et al. Clinical features and outcome of Cogan syndrome[J/OL]. J Pediatr，2012，160（2）：303-307，e1[2021-12-02]. https://doi.org/10.1016/j.jpeds.2011.07.051.
[23] AKROUT R，BENDJEMAA S，FOURATI H，et al. Cerebral rheumatoid vasculitis：a case report[J/OL]. J Med Case Rep，2012，6：302[2021-12-02]. https://doi.org/10.1186/1752-1947-6-302.
[24] BURNS T M. Neurosarcoidosis[J]. Arch Neurol，2003，60（8）：1166-1168.